30 C
Vientiane
Friday, May 9, 2025
spot_img
Home Blog Page 741

TRUMP coin: the signal of crypto era and rise of memecoins by global broker Octa


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 31 January 2025 – Memecoins were on the rise in 2024. Their overall market capitalisation increased from $20 billion last January up to $120 billion in December 2024. Such coins as DOGE, PEPE, or SHIB have thrived, primarily driven by community support and innovative strategies. Some experts have even acknowledged meme coins as a viable crypto trend. TRUMP, a meme coin created by Donald Trump, the 45th and 47th U.S. President, has emerged as a speculative and rather controversial asset. However, it may still signal mass adoption of crypto, regulatory warm-ups and new crypto trends. Global broker Octa explains how the meme coin may impact the market.

Source: Shutterstock
Source: Shutterstock

TRUMP: launch and accelerated growth
Donald Trump surprised society on 17 January 2025, three days before his inauguration, by launching the meme coin TRUMP based on the Solana blockchain. Trump announced the launch on his official X and Truth Social accounts. The coin’s value quickly surged, particularly when it was listed on several CEX (centralised crypto exchanges) like ByBit. Within two days, it increased from $7 on 17 January to $75 on 19 January. The next day, when the President entered the White House, the price soared significantly. The minimum was around $38 per coin. At one point, the coin became the 19th most valuable crypto globally during its peak on 19 January. At the moment of writing the article, the coin ranks 25th on CoinMarketCap in terms of market capitalisation, outperforming popular memecoins like PEPE and, notably, 10-year-old XMR.

TRUMP is considered a memecoin since it has no inherent value, and the asset’s price entirely depends on the market sentiment: buyers and sellers can manipulate the price. Nonetheless, Trump’s fans and crypto enthusiasts have actively supported the coin. The volume of daily traded coins reached its maximum on the inauguration day, 20 January, and surpassed $52 billion.

Currently, the circulating supply accounts for almost a fifth of the whole supply: 200 million tokens. Another 800 million are controlled by Trump-owned entities. The developers plan to release the remaining tokens gradually within three years. However, many experts are concerned because the owner can ruin the market by selling the controlled assets.

MELANIA meme coin: launch and impact on the market
Following the TRUMP coin hype, Melania Trump announced the launch of her own meme coin, MELANIA. While its value almost reached $13 on 20 January, and a lot of crypto traders abandoned TRUMP to trade MELANIA, the asset’s price has dropped since then. The First Lady’s coin was officially presented by her incorporated company, MKT World LLC.

The coin has contributed to the Trump family’s crypto hype. There were even rumours that another coin from Ivanka Trump, the daughter of the elected President, was about to see the world. However, no official news or proof was released, so this could be fake.

The future of TRUMP
TRUMP has been a controversial asset. Some believe it signals ‘a new regulatory era, where governments see crypto as a technology to reach out to the masses directly’. Others are sure that the launch has undermined the credibility of the industry, as the coin is rather volatile and speculative. For example, a popular Bitcoin investor, Erik Voorhees, has criticised the asset.

‘Although TRUMP may be considered as a ‘rug pull’—a quickly abandoned coin—it may have potential longevity. One of the deciding factors is the remaining 80% of the supply and its future’, comments Kar Yong Ang, a financial market analyst at Octa Broker. ‘For now, the future of the asset depends on the crypto society and its willingness to buy TRUMP. This is proved by the MELANIA launch, which shifted liquidity in its favour and significantly dropped the President’s token price.’

Considering the emotion-driven buying frenzy of the TRUMP coin, which potentially drove many newcomers to the crypto market, it’s likely to provoke another rise of memes from celebrities and influencers. While meme coins are known for their high returns, especially during the launch on CEX, they are very volatile and speculative. Traders should avoid quick decisions and overbudgeting to secure their funds.

What is more, it’s advised to beware of scams. For example, there are fake TRUMP tokens now. Moreover, hackers can try to capitalise on the meme hype. Just recently, scammers breached Nasdaq’s X account and promoted a fake meme coin, STONKS. It was launched the same day and was a copycat of a pre-existing memecoin on Solana. Despite this, the project’s market capitalisation reached $80 million. Several days later, the token’s price dropped.

Nonetheless, TRUMP can be considered an evidence of a crypto-favourable regulation. Since Donald Trump was elected as the U.S. President, crypto society has considered this as another proof of an anticipated bull run and crypto mass adoption. For example, Bitcoin hit another ATH (all-time-high) on the inauguration day. This is probably driven by the President’s crypto-related plans, such as industry deregulation or a potential strategic Bitcoin reserve.
Hashtag: #Octa

The issuer is solely responsible for the content of this announcement.

Octa

is an international CFD broker that has been providing online trading services worldwide since 2011. It offers commission-free access to financial markets and various services used by clients from 180 countries who have opened more than 52 million trading accounts. To help its clients reach their investment goals, Octa offers free educational webinars, articles, and analytical tools.

The company is involved in a comprehensive network of charitable and humanitarian initiatives, including the improvement of educational infrastructure and short-notice relief projects supporting local communities.

In the APAC region, Octa received the ‘Best Trading Platform Malaysia 2024’ and the ‘Most Reliable Broker Asia 2023’ awards from Brands and Business Magazine and International Global Forex Awards, respectively.

The President of Chula Meets with Cambodian Minister of Education, a Graduate of the Faculty of Education Strengthening Relations and Integrating Knowledge for Youth in the Region

BANGKOK, Jan. 31, 2025 /PRNewswire/ — Chulalongkorn University reaffirms its role as a regional education leader by strengthening ties with Cambodia. On January 17, 2025, Chulalongkorn University’s executive team, led by Professor Dr. Wilert Puriwat, President of Chulalongkorn University and Chairman of the Council of University Presidents of Thailand (CUPT), paid a courtesy call on His Excellency Dr. Hang Chuon Naron, Deputy Prime Minister and Minister of Education, Youth, and Sports of Cambodia, who also has the distinction of being an alumnus of Chulalongkorn University’s doctoral program in Education Management

Professor Dr. Wilert Puriwat, President of Chulalongkorn University & Chairman of the Council of University Presidents of Thailand (CUPT), paid a courtesy call on His Excellency Dr. Hang Chuon Naron, Deputy Prime Minister and Minister of Education, Youth, and Sports of Cambodia
Professor Dr. Wilert Puriwat, President of Chulalongkorn University & Chairman of the Council of University Presidents of Thailand (CUPT), paid a courtesy call on His Excellency Dr. Hang Chuon Naron, Deputy Prime Minister and Minister of Education, Youth, and Sports of Cambodia

The purpose of this meeting was to further enhance cooperation in education and research, not only between Chulalongkorn University and Cambodia but also to strengthen educational ties between the two countries. The discussion highlighted the fact that education is key to improving quality of life and focused on the integration of Artificial Intelligence (AI) in schools and universities to enhance teaching methods and increase access to education for youth across the region sustainably. This strategic dialogue underscores Chulalongkorn University’s commitment to promoting educational innovation and fostering open collaboration in ASEAN.

Additionally, the group visited the Institute of Technology of Cambodia (ITC) to explore the application of engineering and advanced technology in addressing environmental issues, solar energy generation, and the development of service robots. This visit was facilitated by Professor Dr. Po Kimtho, an alumnus of Chulalongkorn University’s Master’s program in Electronics and Communication Engineering.

Princess Pongmonirath Devi (Nina) Norodom, an alumnus of the Faculty of Communication Arts at Chulalongkorn University, has also played a significant role in representing Chulalongkorn’s impact in cultivating leaders and advancing Cambodian culture. During this visit, Princess Nina shared her impressions of her time at Chula and discussed possible academic and cultural collaborations between the two institutions. 

Dr. Hang Chuon Naron has been instrumental in driving educational reform in Cambodia, applying the knowledge and leadership skills gained at Chulalongkorn University to improve the country’s education system, reflecting the long-standing educational collaboration between the two countries. 

Furthermore, ten Chulalongkorn University alumni from Cambodia took part in the meeting with the minister, demonstrating the university’s popularity among Cambodian students. Many of these alumni have taken on significant roles in education, government, and industry in Cambodia. 

Dr. Hong Kimcheang, an alumnus of the Faculty of Education at Chulalongkorn University and currently the Director of Kampong Speu Institute of Technology (KSIT) and Assistant Minister of the Ministry of Education, played a key role in facilitating this collaboration. 

Currently, there are 11 Cambodian nationals studying and conducting research at Chulalongkorn University. This includes 7 undergraduate students from the Faculty of Dentistry, 1 undergraduate student from the Faculty of Science, 2 researchers from the Faculty of Nursing and the Institute of Social Science Research, and 1 staff member from the Faculty of Medicine.

Read the full article at https://www.chula.ac.th/en/news/212454/

About Chulalongkorn University

Chulalongkorn University has made the world’s top 50 university list for employment outcomes, which reflects both the high employment rate and workability of Chula graduates. The university is also listed as the best in Thailand for the 15th Consecutive Year (since 2009), according to the newly released QS World University Rankings 2024, putting Chula at 211th in the world, up from 244th last year.

Social Media:

Facebook: https://www.facebook.com/ChulalongkornUniversity

Youtube: https://www.youtube.com/chulauniversity

Linkedin: https://www.linkedin.com/school/15101896/

VISTA Eye Specialist Honored as One of Asia’s Top Private Hospitals by Newsweek for 2025

PETALING JAYA, Malaysia, Jan. 31, 2025 /PRNewswire/ — VISTA Eye Specialist (VISTA) is proud to announce its inclusion among Asia’s Top Private Hospitals for 2025, as recognized by the prestigious Newsweek magazine. This accolade highlights VISTA’s unwavering dedication to providing exceptional eye care, prioritizing patient satisfaction, and embracing innovation in ophthalmology.

VISTA Eye Specialist proudly stands among Asia’s Top Private Hospitals 2025 by Newsweek for outstanding eye care.
VISTA Eye Specialist proudly stands among Asia’s Top Private Hospitals 2025 by Newsweek for outstanding eye care.

VISTA’s Leadership in Eye Care

The Newsweek “Top Private Hospitals in Asia” award reaffirms VISTA’s position as an eye care leader in Malaysia and across the region. Known for its cutting-edge technology, highly skilled professionals, and patient-centric approach, VISTA continues to set new standards of excellence in ophthalmology.

Raising the Bar for World-Class Eye Care

Since its establishment, VISTA has revolutionized eye care services in the region with state-of-the-art facilities and a commitment to innovation. The organization consistently achieves superior patient outcomes, reinforcing its reputation as a trusted authority in the field.

“Being recognized by Newsweek is a significant milestone for our team,” said Boon Siong Lim, Founder of VISTA. “This award validates our commitment to delivering world-class eye care and fostering patient trust. Our mission remains clear: to bring better vision and better lives to the communities we serve.”

Innovating with a Focus on Patient Experience

VISTA recently partnered with healthcare expert Shareef Mahdavi to implement the PX Ninety program—a 90-day action-oriented initiative designed to enhance patient experiences, strengthen team collaboration, and optimize practice performance. This partnership underscores VISTA’s proactive approach to redefining patient care and improving healthcare delivery.

Known for its pioneering advancements in vision correction and treatment, VISTA offers a comprehensive range of solutions, including LASIK, CLEAR PRO, and ICL surgeries, as well as advanced treatments for cataracts (including No-Blade Cataract Surgery), children’s myopia, and dry eye disease. Beyond clinical excellence, VISTA prioritizes compassionate, patient-centered care through rigorous staff training and innovative service delivery.

Embedding ESG Principles and Ikigai in Operations

VISTA integrates Environmental, Social, and Governance (ESG) principles into its operations, reinforcing its commitment to sustainability and social responsibility. Recognized with multiple ESG Awards and certified by BCorp—a designation for businesses meeting high social and environmental performance standards—VISTA’s efforts emphasize its role in advancing eye care, supporting community well-being, and promoting environmental stewardship. In 2025, VISTA will be collaborating with Tzu Chi to offer free cataract surgeries for 100 individuals from poor and underserved communities, reinforcing its commitment to making quality eye care accessible to all.

Additionally, VISTA has embraced the Japanese philosophy of Ikigai, which aligns work with purpose and fulfillment. By embedding Ikigai into its culture, VISTA fosters a meaningful and engaging environment for its staff and patients, driving holistic well-being and improved clinical outcomes.

An Award That Fuels Future Ambitions

This recognition inspires VISTA’s continued growth and innovation. Plans for 2025 include expanding its network of centers and integrating advanced AI technologies to enhance clinical care further. VISTA extends its heartfelt gratitude to its key partners, doctors, and dedicated team members for their vital contributions to this achievement.

“This honor is a testament to the collective effort of our entire team,” said Dr. Aloysius Joseph Low, Founder and Medical Director. “It reflects the trust our patients place in us and motivates us to continue innovating, prioritizing safety, and delivering exceptional clinical results.”

With an increasing number of people living to 100 years and beyond, VISTA believes that restoring clear vision enables individuals to fully embrace their golden years and living life to the fullest.

About VISTA Eye Specialist

A member of Qualitas Health Group, VISTA Eye Specialist has been Malaysia’s leading provider of comprehensive ophthalmology services since its founding in 1999. Specializing in cataract and refractive surgeries, VISTA serves thousands of patients annually. Celebrated for its innovative technologies, exceptional care, and highly skilled team, VISTA has solidified its reputation as the region’s gold standard in eye health.

Youxin Technology Ltd Reports Financial Results for Fiscal Year 2024

GUANGZHOU, China, Jan. 31, 2025 /PRNewswire/ — Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their businesses, today announced its financial results for the fiscal year ended September 30, 2024.

Mr. Shaozhang Lin, Chief Executive Officer of Youxin Technology Ltd, commented, “The past year underscores our diligent strategic adjustments and significant efforts to enhance operational efficiency amid macroeconomic headwinds and challenges in China. We successfully improved our gross margins by 5% to 66% overall in fiscal year 2024 from 61% in fiscal year 2023, despite a decline in revenue due to our strategic shift from developing the customized CRM systems toward developing and marketing our third-generation PaaS platform. As PaaS products generally feature more functionalities in contrast to the more hands-on personnel efforts required for customized CRM development services, we managed to reduce operating expenses and increase efficiency. This improvement reflects better cost control, reduced focus on less profitable service lines, and a pivot toward an upgraded portfolio of solutions. Overall, we reduced our net loss by 45.3%, from $2.34 million in fiscal year 2023 to $1.28 million in fiscal year 2024, while maintaining adequate cash reserves to support product development and strategic execution. We remain optimistic about the growth potential and profitability outlook of our third-generation PaaS platform, which is poised for significant enhancements through AI integration in 2025.”

Mr. Lin continued, “Looking ahead, we are confident that our strategic shift, supported by substantial investment, positions us for a turnaround and long-term growth. Our prudent planning, disciplined management, and strict cost controls will further enhance our operational efficiency and financial stability, ultimately delivering long-term value for the Company and our shareholders.”

Fiscal Year 2024 Financial Overview

  • Revenue was $521,241 in fiscal year 2024, compared to $895,978 in fiscal year 2023.
  • Gross profit was $341,593 in fiscal year 2024, compared to $543,302 in fiscal year 2023.
  • Gross margin was 66% in fiscal year 2024, an increase from 61% in fiscal year 2023.
  • Net loss was $1.3 million in fiscal year 2024, compared to $2.3 million in fiscal year 2023.

Fiscal Year 2024 Financial Results

Revenues

Total revenues were $521,241 in fiscal year 2024, or a decrease of 42% from $895,978 in fiscal year 2023. The decrease was mainly because the Company gradually reduced operating the customized CRM system development services.

For the years ended September 30,

2024

2023

($)

Revenue

Cost of
Revenue

Gross
Margin

Revenue

Cost of
Revenue

Gross
Margin

Professional
services

275,314

158,880

42

%

548,822

318,439

42

%

Payment channel
services

206,526

100

%

291,643

100

%

Others

39,401

20,768

47

%

55,513

34,237

38

%

Total

521,241

179,648

66

%

895,978

352,676

61

%

Revenue from professional services was $275,314 in fiscal year 2024, or a decrease of 50% from $548,822 in fiscal year 2023.

  • The Company did not generate revenue from customized CRM system development services in fiscal year 2024. Revenue from customized CRM system development services was $134,768 in fiscal year 2023. The decrease was mainly due to the Company gradually reducing operating Customized CRM system development service.
  • Revenue from the additional function development services was $42,758 in fiscal year 2024, or a decrease of 73% from $155,904 in fiscal year 2023. The decrease was mainly due to the less new needs of the function development from the existing clients for fiscal year 2024.
  • Revenue from subscription services was $232,556 in fiscal year 2024, or a decrease of 10% from $258,150 in fiscal year 2023. The decrease was mainly due to the decreasing customized CRM system development services from 2023, which led to the Company to provide less subscription service in the following periods.

Cost of Revenues

Cost of revenues was $179,648 in fiscal year 2024, a decrease of 49% from $352,676 in fiscal year 2023.

Gross Profit

Gross profit was $341,593 in fiscal year 2024, compared to $543,302 in fiscal year 2023.

Gross margin was 66% in fiscal year 2024, an increase from 61% in fiscal year 2023.

Operating Expenses

Operating expenses were $1.7 million in fiscal year 2024, compared to $3.0 million in fiscal year 2023.

  • Selling expenses were $94,481 in fiscal year 2024, a decrease of 58% from $225,926 in fiscal year 2023. The decrease was mainly due to the decrease in headcount and salaries and welfare. The decrease of salaries and welfare by 59% was primarily due to a decrease in headcount and pay cuts for fiscal year 2024, compared to fiscal year 2023.
  • General and administrative expenses were $496,006 in fiscal year 2024, a decrease of 16% from $589,372 in fiscal year 2023. The decrease was primarily due to a decrease in salaries and welfare of 46% compared to fiscal year 2023 as decrease in headcount and pay cuts.
  • Research and development expenses were $1.1 million in fiscal year 2024, a decrease of 47% from $2.2 million in fiscal year 2023. The decrease was primarily attributed to the decrease in labor related costs including salary and welfare by 47% for fiscal year 2024 compared to fiscal year 2023. Payment made to Cloud Service and other related research and development costs decreased by 43% for fiscal year 2024, which was in line with the operating of business of reducing of CRM development services.

Other Income, Net

Total net other income was $113,367 in fiscal year 2024, compared to $81,360 in fiscal year 2023.

Net Loss

Net loss was $1.3 million in fiscal year 2024, compared to a net loss of $2.3 million in fiscal year 2023.

Basic and Diluted Loss per Share

Basic and diluted loss per share was $0.04 in fiscal year 2024, compared to $0.09 in fiscal year 2023.

Financial Condition

As of September 30, 2024, the Company had cash of $18,372, compared to $399,050 as of September 30, 2023.

Net cash used in operating activities was $728,066 in fiscal year 2024, compared to $2,310,183 in fiscal year 2023.

Net cash provided by investing activities was $360 in fiscal year 2024, compared to $815 in fiscal year 2023.

Net cash provided by financing activities was $431,390 in fiscal year 2024, compared to $484,878 in fiscal year 2023.

Recent Development

The Company’s Class A ordinary shares began trading on the Nasdaq Capital Market on December 20, 2024 under the ticker symbol “YAAS.” On December 23, 2024, the Company completed its initial public offering (the “Offering”) of 2,300,000 Class A ordinary shares at a public offering price of US$4.50 per Class A ordinary share. The Company received aggregate gross proceeds of US$10.35 million from the Offering, before deducting underwriting discounts and other related expenses payable by the Company.

About Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses using its cloud-based SaaS product and PaaS platform to develop, use and control business applications without the need to purchase complex IT infrastructure. Youxin Technology provides a customized, comprehensive, fast-deployment omnichannel digital solutions that unify all aspects of commerce with store innovations, distributed inventory management, cross-channel data integration, and a rich set of ecommerce capabilities that encompass mobile applications, social media, and web-based applications. The Company’s products allow mid-tier brand retailers to use offline direct distribution to connect the management team, distributors, salespersons, stores, and end customers across systems, apps, and devices. This provides retailers with a comprehensive suite of tools to instantly address issues using real-time sales data. For more information, please visit the Company’s website: https://ir.youxin.cloud.

Cautionary Note Regarding Forward-Looking Statements

The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results. 

For investor and media inquiries, please contact:

Youxin Technology Ltd.
Investor Relations Department
Email: ir@youxin.cloud

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com

YOUXIN TECHNOLOGY LTD

CONSOLIDATED BALANCE SHEETS

AS OF SEPTEMBER 30, 2024 AND 2023

(Expressed in U.S. dollars, except for the number of shares)

September
30, 2024

September
30, 2023

ASSETS

CURRENT ASSETS

Cash

$

18,372

$

399,050

Restricted cash

24,649

Accounts receivable, net

176,607

233,481

Prepaid expenses and other current assets

122,676

140,696

Total current assets

342,304

773,227

NON-CURRENT ASSETS

Property and equipment, net

3,948

11,696

Deferred offering costs

478,108

117,215

Operating lease right-of-use assets

123,170

85,662

Other non-current assets

10,608

27,558

Total non-current assets

615,834

242,131

TOTAL ASSETS

$

958,138

$

1,015,358

LIABILITIES

CURRENT LIABILITIES

Short-term bank loan

$

323,472

$

311,129

Accounts payable

31,350

52,448

Contract liabilities

215,768

166,628

Amount due to related parties

1,067,119

274,836

Operating lease liabilities – current

42,277

85,082

Payroll payable

1,869,436

1,465,220

Accrued expenses and other current liabilities

40,299

21,192

Total current liabilities

3,589,721

2,376,535

Operating lease liabilities – non-current

82,674

363

Total non-current liabilities

82,674

363

TOTAL LIABILITIES

$

3,672,395

$

2,376,898

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS’ DEFICIT

Class A ordinary shares, ($0.0001 par value, 400,000,000 shares
authorized, 22,304,693 shares issued and outstanding as of September
30, 2024 and 2023, respectively)

2,230

2,230

Class B ordinary shares, ($0.0001 par value, 100,000,000 shares
authorized, 8,945,307 shares issued and outstanding as of September 30,
2024 and 2023, respectively)

895

895

Share subscription receivables

(3,125)

(3,125)

Additional paid-in capital

12,154,929

12,154,929

Accumulated deficit

(15,419,765)

(14,139,104)

Accumulated other comprehensive income

550,579

622,635

Total shareholders’ deficit

(2,714,257)

(1,361,540)

TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT

$

958,138

$

1,015,358

YOUXIN TECHNOLOGY LTD

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE YEARS ENDED SEPTEMBER 30, 2024, 2023 AND 2022

(Expressed in U.S. dollars, except for the number of shares)

2024

2023

2022

Years Ended September 30,

2024

2023

2022

REVENUES

$

521,241

$

895,978

$

1,277,066

COST OF REVENUES

(179,648)

(352,676)

(581,339)

GROSS PROFIT

341,593

543,302

695,727

OPERATING EXPENSES

Selling expenses

(94,481)

(225,926)

(934,744)

General and administrative expenses

(496,006)

(589,372)

(1,276,127)

Research and development expenses

(1,139,922)

(2,152,602)

(5,257,256)

Total operating expenses

(1,730,409)

(2,967,900)

(7,468,127)

NET LOSS FROM OPERATIONS

(1,388,816)

(2,424,598)

(6,772,400)

OTHER INCOME, NET

Other income

134,802

99,053

349,797

Other expense

(21,435)

(17,693)

(34,280)

Total other income, net

113,367

81,360

315,517

NET LOSS BEFORE TAXES

(1,275,449)

(2,343,238)

(6,456,883)

Income tax expense

(5,212)

NET LOSS

(1,280,661)

(2,343,238)

(6,456,883)

Accretion to redeemable preferred equity

(326,837)

(605,659)

Net loss attributable to ordinary shareholders

(1,280,661)

(2,670,075)

(7,062,542)

NET LOSS

(1,280,661)

(2,343,238)

(6,456,883)

Other comprehensive loss

Foreign currency translation (loss) income

(72,056)

(212,292)

895,745

TOTAL COMPREHENSIVE LOSS

$

(1,352,717)

$

(2,555,530)

$

(5,561,138)

Basic and diluted loss per share

$

(0.04)

$

(0.09)

$

(0.27)

*Weighted average number of ordinary shares
outstanding – basic and diluted

31,335,616

28,204,585

25,931,452

* Giving retroactive effect to the issuance of shares effected on April 21, 2023.

YOUXIN TECHNOLOGY LTD

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED SEPTEMBER 30, 2024, 2023 AND 2022

(Expressed in U.S. dollars, except for the number of shares)

2024

2023

2022

Years Ended September 30

2024

2023

2022

Cash flows from operating activities

Net loss

$

(1,280,661)

$

(2,343,238)

$

(6,456,883)

Adjustments to reconcile net loss to cash used in
operating activities:

Loss (gain) on disposal of property and equipment

572

(357)

Amortization of right-of-use assets

101,888

204,715

481,504

Depreciation

6,816

12,293

14,717

Credit loss provision

4,664

Loss from termination of right-of-use assets

183

369

Changes in assets and liabilities

Accounts receivable

52,210

94,595

(16,181)

Prepaid expenses and other current assets

18,020

69,605

(87,583)

Deferred contract costs

30,192

(7,184)

Other non-current assets

16,950

28,368

24,131

Accounts payable

(21,098)

(14,007)

27,495

Operating lease liabilities

(100,073)

(207,881)

(507,521)

Payroll Payable

404,216

102,096

1,040,790

Accrued expenses and other current liabilities

19,107

(18,026)

(4,532)

Contract liabilities

49,140

(268,907)

217,491

Net cash used in operating activities

(728,066)

(2,310,183)

(5,273,756)

Cash flows from investing activities

Purchase of property and equipment

(1,618)

Proceeds from dispose of property and equipment

360

815

Repayment from a related party

768,380

Net cash provided by investing activities

360

815

766,762

Cash flows from financing activities

Loan from related parties

792,283

284,292

Proceeds from short-term bank loan

321,834

Payment of deferred offering cost

(360,893)

(121,248)

Net cash provided by financing activities

431,390

484,878

Effect of exchange rates on cash and cash equivalents
and restricted cash

(59,713)

5,194

(312,986)

Net decrease in cash and cash equivalents and
restricted cash

(356,029)

(1,819,296)

(4,819,980)

Cash and cash equivalents at beginning of year

399,050

2,218,346

7,038,326

Cash and cash equivalents and restricted cash at end
of year

$

43,021

$

399,050

$

2,218,346

Cash and cash equivalents

18,372

399,050

1,802,236

Restricted cash

24,649

416,110

Cash and cash equivalents and restricted cash at end
of year

43,021

399,050

$

2,218,346

Cash paid for interest expenses

$

10,237

$

257

$

Cash paid for income tax

$

$

$

Supplemental disclosure of non-cash financing
activities:

Accretion to redeemable preferred equity

$

$

326,837

$

605,659

Exchange redeemable preferred equity with Class A
ordinary shares

$

$

12,154,929

$

Operating lease right-of-use assets obtained in exchange
for operating lease liabilities

$

140,844

$

$

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

MELBOURNE, Australia and INDIANAPOLIS, Jan. 31, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition from antibody engineering company ImaginAb, Inc. (ImaginAb). The acquisition includes a pipeline of next-generation therapeutic candidates, a proprietary novel biologics technology platform, and a protein engineering and discovery research facility to enhance existing innovation capabilities[1].

This transaction delivers a pipeline of drug candidates against validated cancer targets including DLL3[2] and integrin αvβ6[3], as well as a panel of other agents against novel targets in early discovery stage. The Company believes that these next generation drug candidates fit synergistically with Telix’s therapeutics pipeline, enabling expansion to future therapy areas with unmet clinical need.

The technology platform and intellectual property utilizes small, engineered antibody formats that enable highly specific targeting of cancer with radiation, that exhibit fast tumor uptake and blood clearance. This technology has the potential to be highly effective for imaging and treating tumors with a broad range of radioisotopes, with alpha emitters of particular interest. The ImaginAb capabilities combined with Telix’s existing investments in new target development, conjugation and isotope processing has resulted in a platform that has the potential to rapidly create a new portfolio of “next generation” theranostic radiopharmaceuticals.

The transaction adds a state-of-the-art research facility in Los Angeles to Telix’s U.S. operations, complementing the Company’s existing radiochemistry platform at Optimal Tracers (Sacramento, CA), isotope production at ARTMS (Vancouver, Canada) and bioconjugation chemistry at IsoTherapeutics (Angleton, TX). ImaginAb’s team of discovery, protein engineering and radiopharmaceutical development experts will also join the Telix early development team, further enhancing in-house capabilities in antibody engineering, protein characterization and preclinical development.   

Dr. Michael Wheatcroft, Chief Scientist, Telix, said, “The addition of an early-stage pipeline of promising theranostic assets and a novel biologics platform adds new optionality for Telix to create the next generation of precision medicine and therapeutic products, beyond the current clinical-stage pipeline. We are particularly delighted to welcome a talented team of experts, further enhancing Telix’s R&D capabilities.”

Dr. Anna M. Wu, Co-Founder and Board Member, ImaginAb, added, “The innovative radiotherapeutic technology platform is designed to optimize radiopharmaceutical therapies with targeting agents that are more selective and better match the pharmacology and radiobiology of a given radionuclide. The protein engineering and discovery team is excited to join Telix and further unlock the future potential of this platform and theranostic candidates.”

Transaction details

The upfront consideration value was US$45 million (AU$73 million)[4] of which US$10 million (AU$16 million) has been paid to ImaginAb in cash, with US$31 million (AU$50 million) paid in equity through the issue of 2,053,311 fully paid ordinary Telix shares at AU$24.3745 per share[5]. A deferred payment of up to US$4 million will be paid to ImaginAb in equity at the conclusion of a 15-month indemnity period, subject to set-off of any substantiated claims by Telix above a threshold amount. Upfront equity consideration is subject to voluntary escrow (lock-up/leak-out) restrictions[6].

Upon achievement of specific key development and commercial milestones, Telix will pay up to a total of US$185 million (AU$299 million), a portion of which may be paid in cash or equity at Telix’s election[7]. Royalties are also payable on net sales in the low single digits on a limited number of platform and early-stage products after the first four products have been developed, as well as single-digit sublicense fees, as applicable. 

About ImaginAb, Inc.

ImaginAb is a clinical stage global biotechnology company developing the next generation of radiopharmaceutical imaging agent products. These patented products contain engineered antibodies that maintain the specificity of full-length antibodies while remaining biologically inert in the body. Used with widely available positron emission tomography (PET) and optical imaging technology, these novel targeting agents are able to bind specifically to cell surface targets.

Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical and biotech companies for use in imaging within immunotherapy clinical trials, primarily in oncology.

Jefferies LLC and Stifel, Nicolaus & Company, Incorporated served as financial advisors to ImaginAb on the transaction.

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. ARTMS, IsoTherapeutics, Lightpoint, Optimal Tracers and RLS are Telix Group companies. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).

Telix’s lead prostate imaging product, gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)[8], by the Australian Therapeutic Goods Administration (TGA)[9], and by Health Canada[10]. Telix has received a positive decision on its Marketing Authorization Application (MAA) for Illuccix submitted in Europe[11].

Telix’s osteomyelitis (bone infection) imaging agent, technetium-99m (99mTc) besilesomab, marketed under the brand name Scintimun®, is approved in 32 European countries and Mexico. Telix’s miniaturized surgical gamma probe, SENSEI®, for minimally invasive and robotic-assisted surgery, is registered with the FDA for use in the U.S. and has attained a Conformité Européenne (CE) Mark for use in the European Economic Area. No other Telix product has received a marketing authorization in any jurisdiction.

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and SEC filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedInX and Facebook.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board.

Legal Notices

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the anticipated benefits of Telix’s transaction with ImaginAb; the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

 ©2025 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Telix Group company, and Telix product names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. Trademark registration status may vary from country to country.

[1] Refer to Telix ASX disclosure 13 January 2025.

[2] Delta-like ligand 3, a cell surface protein overexpressed in high-grade neuroendocrine tumors and small cell lung cancer (SCLC).

[3] Integrin αvβ6 is a cell surface protein overexpressed during wound healing and in cancer.

[4] All references to AUD have been converted at the AUD/USD exchange rate of 1.614.  

[5] Volume weighted average price of shares (VWAP) for the 10 trading day period up to and including 10 January 2025. Refer to Appendix 2A lodged with ASX today for further details.

[6] Refer to Appendix 2A lodged with ASX today for further details.

[7] Refer to Appendix 3G lodged with ASX today for further details.

[8] Telix ASX disclosure 20 December 2021.

[9] Telix ASX disclosure 2 November 2021.

[10] Telix ASX disclosure 14 October 2022.

[11] Telix ASX disclosure 17 January 2025.

 

Growth Opportunities in the Generator Service Market, Global, 2024-2034

Digital Advancements Are Driving Transformative Growth Opportunities

SAN ANTONIO, Jan. 31, 2025 /PRNewswire/ — The global generator service market is projected to grow at a rate of 2.8% from 2023 to 2034, driven by rising power demand and increasing customer awareness of digital solutions. Real-time visibility into equipment operations and AI-powered analytics provide critical insights that enhance efficiency, support predictive maintenance, and ensure continuous usage. By leveraging advanced analytics, manufacturers can optimize equipment control, utilization, logistics, and procurement. Among all end-user sectors, predictive applications remain the most essential in the generator market.

Expansion of the Data Center Market Fuels Investment in Digital Services

The rapid expansion of the data center market is a key driver of investment in digital services. As data centers grow, demand for innovative solutions that improve asset performance, enable proactive maintenance, and facilitate real-time management across multiple locations is increasing. Technologies such as Big Data, edge and cloud computing, and AI are shaping sales strategies. Initial adoption is expected to focus on solutions that deliver immediate cost savings and operational benefits, including fuel monitoring, asset tracking, predictive maintenance alerts, and remote monitoring services.

XaaS Models Enhance Competitive Advantage

OEMs are increasingly recognizing the potential of Everything-as-a-Service (XaaS) models. While generator set (genset) rentals have been available for some time and are expected to continue growing, many OEMs are now exploring performance-based contracts. These agreements allow customers to acquire equipment gradually through lease-to-buy options, reducing upfront costs and expanding accessibility.

Lucrecia Gomez, Global Power & Energy Research Director at Frost & Sullivan, comments: “Manufacturing high-quality generators alone will not be enough for long-term success. Over time, diesel gensets will become commodities. Companies that produce gensets must show their capability to provide services that utilize the latest technology and digital service models. Genset OEMs should focus on increasing customer loyalty and exploring new revenue streams through digital services, enhanced sponsorship opportunities, and improved customer awareness..”

She adds, “Deploying value-added tools such as fuel monitoring; asset utilization and tracking; equipment maintenance indications; and remote monitoring will enhance product penetration among targeted end users. These advancements will contribute to faster market growth. We forecast deployment to expand at a 4.7% CAGR to 2034.”

To stay ahead in the rapidly evolving generator service and digital solutions landscape, find out more about the growth opportunities here.

Frost & Sullivan, the growth pipeline company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation, and leadership. The company’s Growth Pipeline as a Service provides the CEO and the CEO’s Growth Team with transformational strategies and best-practice models to drive the generation, evaluation, and implementation of powerful growth initiatives. Frost & Sullivan leverages over 60 years of experience in partnering with Global 1000 companies, emerging businesses, and the investment community from more than 40 offices on six continents.

Contact:
Celeste Bailo
Marketing & Communications
Global Customer Experience, Frost & Sullivan
celeste.bailo@frost.com

American Creators Score Major Wins at BIGO Awards Gala 2025

  • American creators like Taylor Breanna, Alexis Elise Scott received major awards at the BIGO Awards Gala in Singapore.
  • With over 1000 guests in attendance, this year’s gala highlights Bigo Live’s top priority of ensuring user safety while fostering freedom and innovation in content creation, offering content creators and viewers a diverse and harmonious experience.

LOS ANGELES, US – Media OutReach Newswire – 30 January 2025 – American creators including Taylor Breanna, Jarran Muse and Alexis Elise Scott, scored major wins at last Friday’s Bigo Live Awards. The highly anticipated BIGO Awards Gala is now in its sixth edition and organized by leading global social live-streaming platform Bigo Live.

This year’s theme, “LIVE YOUR OASIS,” reflects Bigo Live’s dedication to celebrating creativity, community and sustainability while fostering a safe and innovative digital ecosystem. The award ceremony was held at the iconic Marina Bay Sands, Sands Theatre, marking a significant milestone as it returns to Singapore, the birthplace of Bigo Live.

The gala welcomed an audience of over 1,000 in-person attendees from around the world, while more than 140,000 viewers tuned in online. The evening was a dazzling celebration of global connection and creative achievements. Attendees experienced an unforgettable night of recognition, entertainment and interaction, highlighting the platform’s ongoing commitment to fostering an inclusive and innovative environment for creators and audiences worldwide.

Co-hosted by renowned Singaporean actress and radio DJ Vernetta Lopez and stand-up comedian Rishi Budhrani, the evening kicked off with an electrifying opening song lit up by a spirited EDM performance. Thirty-five performers from around the world, including Jarran Muse from America, delivered a spectacular array of acts, ranging from pop, opera, hip-hop and rock music to acrobatics and dance. This dynamic celebration of cultural fusion underscores the universal power of the arts.

The Gala’s centrepiece is the recognition of exceptional content creators. Over 200 creators and families were honored across categories such as “Most Uplifting Livestream,” “Best Family Content,” and “Global Community Builder.” Categories like “Most Popular Host,” “Most Popular Family,” and “Gala Star” highlight the platform’s emphasis on community engagement and inclusivity.

American creators such as Taylor Breanna and Alexis Elise Scott received multiple accolades at the gala, a testament to their popularity. They received trophies and in-app rewards. Because viewers played an active role in the celebration by voting for their favorite creators in real-time during the event, this indicates the popularity of American creators not just in the United States but in other countries.

In 2025, Bigo Live will launch further community initiatives and programs to champion its creators. These include spotlighting the voices of our diverse community, fundraising campaigns for meaningful causes and masterclasses in partnership with non-profit organizations on content creation for education and advocacy.

“We are really glad to see creators like Jarran Muse, Trac Trac and Taylor Breanna have their time in the limelight at the BIGO Awards Gala 2025. Bigo Live is a platform that connects creators of common interests across the world, so it is heartening to see that our creators are connecting with people thousands of miles away, on another continent,” said Eric Kim, Senior Operations Director at Bigo Live.

Commitment to Safety, Innovation and Sustainability in Live Streaming

Digital content consumption continues to grow at an unprecedented pace, positioning livestreaming as a transformative force reshaping the social media landscape. Since its inception in 2016, platforms like Bigo Live have been at the forefront of this evolution, enabling creators to reach global audiences with ease. According to a recent report by Stream Hatchet, Bigo Live ranked as the 7th most popular live-streaming platform worldwide in Q3 2024, reflecting its significant impact on the industry.

Through innovative tools such as a Virtual Live and tailored content incentives, Bigo Live has created a thriving ecosystem for creators and viewers alike. The platform’s continuous investment in technological advancements has empowered users to enhance digital interactions and explore new frontiers in creativity.

Through its User-Generated Content (UGC) policies, including stricter private stream verification, advanced moderation practices to reduce oversight gaps and locally relevant content criteria – Bigo Live strives to make the platform a true online oasis for creators and viewers alike, where creativity thrives and connections flourish.

In alignment with its commitment to a greener future, this year’s gala was a carbon-neutral event. By measuring carbon emissions from materials, transportation and electricity and offsetting them with carbon credits, this initiative marks the first step in identifying emission sources and hotspots. Bigo Live emphasizes its role as a responsible industry leader, setting new standards for environmentally conscious digital platforms.
Hashtag: #bigo #bigolive #bigoawardsgala

The issuer is solely responsible for the content of this announcement.

Bigo Live

Bigo Live is one of the world’s fastest-growing live-streaming social communities where users broadcast in real-time to share life moments, showcase their talents and interact with people from around the world. Bigo Live has around 500 million users in over 150 countries and is currently the market leader in the live streaming industry. Launched in March 2016, Bigo Live is owned by Bigo Technology, based in Singapore.

Extended Reality, the Newest Frontier of the Energy Transition

The need for immersive technologies will reshape business strategies and drive seamless integration across industries

LONDON, Jan. 31, 2025 /PRNewswire/ — The global energy industry is undergoing a transformation driven by decarbonisation and decentralisation, leading to increased digitalisation and the utilisation of extended reality (ER) technologies.

Over the past three years, the foundations of the virtual reality (VR) and augmented/mixed reality (AR-MR) markets have become stronger, with major companies investing billions of dollars to stimulate the growth of these technologies.

Extended reality plays a crucial role in the energy sector’s digital transformation, offering users immersive experiences within intricately designed 3D virtual environments. This integration of immersive technology is changing how industry professionals interact with complex data and processes, ultimately leading to innovative solutions and improved efficiency in energy management and operations.

A Growing Market with Extensive Potential for Partnerships and Collaboration

Frost & Sullivan forecasts an impressive compound annual growth rate (CAGR) of 49.4% in global VR/AR-MR market revenues from 2023 to 2028. This growth is fuelled by continuous advancements in immersive technologies and the increase in both consumer and business interest.

The full potential of industrial extended reality (XR) hardware lies in its adaptability to diverse applications. Unlike consumer solutions, industrial XR often requires customisation for specific sectors, such as energy.

Collaboration across the industry is essential to unlocking this potential. By developing specialised software development kits (SDKs) and advanced functionalities, stakeholders can ensure seamless integration of XR technologies into existing workflows and infrastructure, driving innovation and efficiency across industrial domains.

Seamless Integration of Cross-Industry Solutions

Integrating cross-industry solutions is crucial for successful XR implementations in the power and energy sectors. Leveraging advanced technologies such as AI analytics, digital twins, process simulations, and XR platforms enables companies to simulate asset operations in real time. This approach supports informed decision-making, enhances operational efficiency, and mitigates risks.

For instance, digital twins can facilitate the integration of distributed energy resources (DER) into the grid, enhancing the operation of generation and storage assets, and delivering enhanced customer experiences. By adopting these innovative tools, the power and energy sectors can drive greater resilience, sustainability, and performance.

Lucrecia Gomez, Global Power & Energy Research Director at Frost & Sullivan, comments: “Our annual survey of IT decision-makers revealed that 58% of respondents possess a high or moderate level of expertise in immersive digital services within the energy sector. As the industry matures and the demand for ER continues to rise, the visibility and adoption of these technologies will quickly increase across organisations worldwide.”

Gomez adds: “The majority of organisations (62%) are actively engaged in small, medium, or large-scale trials and proof-of-concept projects involving immersive digital services. Among these technologies, mixed reality (MR) stands out, capturing the highest level of interest, with 20% of respondents expressing that they are very or extremely interested in its applications.”

Looking ahead, augmented reality (AR) and mixed reality (MR) are expected to gain significant traction across various business use cases, including data centres, oil and gas, solar photovoltaics, and nuclear power, among others. These technologies hold immense potential to drive innovation and efficiency in the energy sector.

To stay ahead in the fast-expanding global VR/AR-MR landscape, find out more about the growth opportunities here.

Frost & Sullivan, the growth pipeline company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation, and leadership. The company’s Growth Pipeline as a Service provides the CEO and the CEO’s Growth Team with transformational strategies and best-practice models to drive the generation, evaluation, and implementation of powerful growth initiatives. Frost & Sullivan leverages over 60 years of experience in partnering with Global 1000 companies, emerging businesses, and the investment community from more than 40 offices on six continents.

Contact:

Kristina Menzefricke
Marketing & Communications
Global Customer Experience, Frost & Sullivan
kristina.menzefricke@frost.com